Answers are grounded in this paper and cite their sources.
Out of the blue: The marine macrolide spirastrellolide A is a potent and selective inhibitor of protein phosphatase 2A and a lead for anticancer therapies. A flexible and modular synthetic strategy has been developed with two routes for the construction of the DEF bis-spiroacetal subunit. The optimized Suzuki coupling approach results in the efficient preparation of a C17–C40 aldehyde that forms the cornerstone of the first total synthesis.
No takes yet. Share an insight, caveat, or question.
Paterson et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: